Leukemia Research
Volume 27, Issue 6 , Pages 517-527, June 2003

Flavonoid effects on normal and leukemic cells

  • Jane L Liesveld

      Affiliations

    • Department of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
    • Corresponding Author InformationCorresponding author. Present address: Bux Fuy Strong Memorial Hospital, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA. Tel.: +1-585-275-4099; fax: +1-585-273-1051.
  • ,
  • Camille N Abboud

      Affiliations

    • Department of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
  • ,
  • Chaohui Lu

      Affiliations

    • Department of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
  • ,
  • Curtiss McNair II

      Affiliations

    • Department of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
  • ,
  • Aarti Menon

      Affiliations

    • Department of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
  • ,
  • Alan Smith

      Affiliations

    • Department of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
  • ,
  • Karen Rosell

      Affiliations

    • Department of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
  • ,
  • Aaron P Rapoport

      Affiliations

    • Greenebaum Cancer Center, The University of Maryland, Baltimore, MD, USA

Received 20 June 2002; accepted 4 October 2002.

Abstract 

Quercetin and flavopiridol, both flavonoids which influence oxidative milieu, proliferation, and apoptosis of various cell types, were examined for their effects on acute myelogenous leukemic cells and normal progenitors. Both quercetin and flavopiridol inhibited the growth and viability of various acute myelogenous leukemia (AML) cell lines and AML blasts isolated afresh from patients with AML of various subtypes. The effects on inhibition of proliferation and decreased viability were also significant in normal CD34+ cells isolated from normal marrow donors. In certain AML cases, the effects of flavopiridol appeared to be mediated through activation of caspase 3, offering one possible mechanism for the apoptosis evident after exposure to flavopiridol as measured by annexin V expression. These flavonoid compounds might find use in various therapeutic settings in AML.

Abbreviations:  AML, acute myelogenous leukemia, PBS, phosphate buffered saline, EDTA, ethylenediamine tetraacetic acid, BSA, bovine serum albumin, FcR, Fc receptor, FACS, fluorescence activated cell sorting, LTC-IC, long-term culture initiating cell, CFU-GM, granulocyte–macrophage colony forming unit, AML-CFC, AML colony forming cell, TdT, terminal deoxynucleotidyl transferase, PI, propidium iodide, GM-CSF, granulocyte–macrophage colony stimulating factor, IL-3, interleukin-3, SCF, stem cell factor, FAB, French American British

Keywords:  Quercetin, Flavopiridol, Apoptosis, Proliferation, Caspase 3

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by ACS grant DHP-173. JLL is a Clinical Scholar of the Leukemia and Lymphoma Society of America.

PII: S0145-2126(02)00265-5

doi:10.1016/S0145-2126(02)00265-5

Leukemia Research
Volume 27, Issue 6 , Pages 517-527, June 2003